お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は性感染症検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは性感染症検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の性感染症検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは性感染症検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に性感染症検査市場を分類しています。本研究に含まれる主な企業は：BioMerieux、F. Hoffmann La Roche、BD、Abbott、Bio-Rad Laboratories、Abbott、Qiagen

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Chlamydia Testing
    Gonorrhea Testing
    Syphilis Testing
    HIV Testing
    HSV Testing
    HPV Testing
    Chancroid Testing
    Other

用途別の市場セグメント：
    Clinics
    Hospitals
    Other

本レポートの詳細内容
世界の性感染症検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、性感染症検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の性感染症検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の性感染症検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、性感染症検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

性感染症検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：性感染症検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：性感染症検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章性感染症検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：性感染症検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：性感染症検査の主要企業の概要を提供し、製品の説明と仕様、性感染症検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
Market Analysis and Insights: Global Sexually Transmitted Diseases Testing Market
The global Sexually Transmitted Diseases Testing market is projected to grow from US$ 80070 million in 2024 to US$ 104270 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.
Report Covers:
This report presents an overview of global market for Sexually Transmitted Diseases Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Sexually Transmitted Diseases Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Diseases Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexually Transmitted Diseases Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sexually Transmitted Diseases Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sexually Transmitted Diseases Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Abbott and Qiagen, etc.
Market Segmentation
By Company
    BioMerieux
    F. Hoffmann La Roche
    BD
    Abbott
    Bio-Rad Laboratories
    Abbott
    Qiagen

Segment by Type
    Chlamydia Testing
    Gonorrhea Testing
    Syphilis Testing
    HIV Testing
    HSV Testing
    HPV Testing
    Chancroid Testing
    Other

Segment by Application
    Clinics
    Hospitals
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sexually Transmitted Diseases Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexually Transmitted Diseases Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chlamydia Testing
    Table 3. Key Players of Gonorrhea Testing
    Table 4. Key Players of Syphilis Testing
    Table 5. Key Players of HIV Testing
    Table 6. Key Players of HSV Testing
    Table 7. Key Players of HPV Testing
    Table 8. Key Players of Chancroid Testing
    Table 9. Key Players of Other
    Table 10. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 11. Global Sexually Transmitted Diseases Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Sexually Transmitted Diseases Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Sexually Transmitted Diseases Testing Market Share by Region (2019-2024)
    Table 14. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Sexually Transmitted Diseases Testing Market Share by Region (2025-2030)
    Table 16. Sexually Transmitted Diseases Testing Market Trends
    Table 17. Sexually Transmitted Diseases Testing Market Drivers
    Table 18. Sexually Transmitted Diseases Testing Market Challenges
    Table 19. Sexually Transmitted Diseases Testing Market Restraints
    Table 20. Global Sexually Transmitted Diseases Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Sexually Transmitted Diseases Testing Revenue Share by Players (2019-2024)
    Table 22. Global Top Sexually Transmitted Diseases Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2023)
    Table 23. Global Sexually Transmitted Diseases Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 24. Global 5 Largest Players Market Share by Sexually Transmitted Diseases Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Global Key Players of Sexually Transmitted Diseases Testing, Headquarters and Area Served
    Table 26. Global Key Players of Sexually Transmitted Diseases Testing, Product and Application
    Table 27. Global Key Players of Sexually Transmitted Diseases Testing, Product and Application
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2019-2024)
    Table 31. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2025-2030)
    Table 33. Global Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Sexually Transmitted Diseases Testing Revenue Share by Application (2019-2024)
    Table 35. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Sexually Transmitted Diseases Testing Revenue Share by Application (2025-2030)
    Table 37. North America Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 38. North America Sexually Transmitted Diseases Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 39. North America Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 40. North America Sexually Transmitted Diseases Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 41. North America Sexually Transmitted Diseases Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. North America Sexually Transmitted Diseases Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 43. North America Sexually Transmitted Diseases Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Europe Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 45. Europe Sexually Transmitted Diseases Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 46. Europe Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 47. Europe Sexually Transmitted Diseases Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 48. Europe Sexually Transmitted Diseases Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Europe Sexually Transmitted Diseases Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Europe Sexually Transmitted Diseases Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 51. China Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 52. China Sexually Transmitted Diseases Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 53. China Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 54. China Sexually Transmitted Diseases Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 56. Asia Sexually Transmitted Diseases Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 57. Asia Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 58. Asia Sexually Transmitted Diseases Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 59. Asia Sexually Transmitted Diseases Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 60. Asia Sexually Transmitted Diseases Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 61. Asia Sexually Transmitted Diseases Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 67. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 69. BioMerieux Company Details
    Table 70. BioMerieux Business Overview
    Table 71. BioMerieux Sexually Transmitted Diseases Testing Product
    Table 72. BioMerieux Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 73. BioMerieux Recent Developments
    Table 74. F. Hoffmann La Roche Company Details
    Table 75. F. Hoffmann La Roche Business Overview
    Table 76. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product
    Table 77. F. Hoffmann La Roche Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 78. F. Hoffmann La Roche Recent Developments
    Table 79. BD Company Details
    Table 80. BD Business Overview
    Table 81. BD Sexually Transmitted Diseases Testing Product
    Table 82. BD Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 83. BD Recent Developments
    Table 84. Abbott Company Details
    Table 85. Abbott Business Overview
    Table 86. Abbott Sexually Transmitted Diseases Testing Product
    Table 87. Abbott Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 88. Abbott Recent Developments
    Table 89. Bio-Rad Laboratories Company Details
    Table 90. Bio-Rad Laboratories Business Overview
    Table 91. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product
    Table 92. Bio-Rad Laboratories Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 93. Bio-Rad Laboratories Recent Developments
    Table 94. Abbott Company Details
    Table 95. Abbott Business Overview
    Table 96. Abbott Sexually Transmitted Diseases Testing Product
    Table 97. Abbott Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 98. Abbott Recent Developments
    Table 99. Qiagen Company Details
    Table 100. Qiagen Business Overview
    Table 101. Qiagen Sexually Transmitted Diseases Testing Product
    Table 102. Qiagen Revenue in Sexually Transmitted Diseases Testing Business (2019-2024) & (US$ Million)
    Table 103. Qiagen Recent Developments
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Sexually Transmitted Diseases Testing Market Share by Type: 2023 VS 2030
    Figure 3. Chlamydia Testing Features
    Figure 4. Gonorrhea Testing Features
    Figure 5. Syphilis Testing Features
    Figure 6. HIV Testing Features
    Figure 7. HSV Testing Features
    Figure 8. HPV Testing Features
    Figure 9. Chancroid Testing Features
    Figure 10. Other Features
    Figure 11. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Sexually Transmitted Diseases Testing Market Share by Application: 2023 VS 2030
    Figure 13. Clinics Case Studies
    Figure 14. Hospitals Case Studies
    Figure 15. Other Case Studies
    Figure 16. Sexually Transmitted Diseases Testing Report Years Considered
    Figure 17. Global Sexually Transmitted Diseases Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Sexually Transmitted Diseases Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Sexually Transmitted Diseases Testing Market Share by Region: 2023 VS 2030
    Figure 20. Global Sexually Transmitted Diseases Testing Market Share by Players in 2023
    Figure 21. Global Top Sexually Transmitted Diseases Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases Testing Revenue in 2023
    Figure 23. North America Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Sexually Transmitted Diseases Testing Market Share by Type (2019-2030)
    Figure 25. North America Sexually Transmitted Diseases Testing Market Share by Application (2019-2030)
    Figure 26. North America Sexually Transmitted Diseases Testing Market Share by Country (2019-2030)
    Figure 27. United States Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Sexually Transmitted Diseases Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Sexually Transmitted Diseases Testing Market Share by Type (2019-2030)
    Figure 31. Europe Sexually Transmitted Diseases Testing Market Share by Application (2019-2030)
    Figure 32. Europe Sexually Transmitted Diseases Testing Market Share by Country (2019-2030)
    Figure 33. Germany Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Sexually Transmitted Diseases Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Sexually Transmitted Diseases Testing Market Share by Type (2019-2030)
    Figure 41. China Sexually Transmitted Diseases Testing Market Share by Application (2019-2030)
    Figure 42. Asia Sexually Transmitted Diseases Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Sexually Transmitted Diseases Testing Market Share by Type (2019-2030)
    Figure 44. Asia Sexually Transmitted Diseases Testing Market Share by Application (2019-2030)
    Figure 45. Asia Sexually Transmitted Diseases Testing Market Share by Region (2019-2030)
    Figure 46. Japan Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Sexually Transmitted Diseases Testing Market Share by Country (2019-2030)
    Figure 56. Brazil Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Sexually Transmitted Diseases Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. BioMerieux Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 63. F. Hoffmann La Roche Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 64. BD Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 65. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 67. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 68. Qiagen Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed